Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 +0.01 (+0.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Other Operating Expenses (2023 - 2024)

Updated

Telomir Pharmaceuticals (TELO) reported Other Operating Expenses of $370,500 for FY2024, down 79.0% from $1.77 million in FY2023.

Analysis

Telomir Pharmaceuticals (TELO) Other Operating Expenses (2023 - 2024) Analysis & Trends

  • According to Business Quant data, Other Operating Expenses came in at $1.77 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 370,500.00
Dec 31, 2023 479,550.00
Sep 30, 2023 589,400.00
Jun 30, 2023 698,600.00
API Access

Telomir Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEY